CHEMED director granted 386 shares in stock award

CHEMED CORP director Eileen P. McCarthy received an award of 386 shares of Capital Stock as compensation.

Rhea-AI Filing Summary

CHEMED CORP director Eileen P. McCarthy received an award of 386 shares of Capital Stock as compensation. The shares were granted on May 18, 2026 at a value of $440.77 per share, described as an award of stock.

Following this non-market acquisition, McCarthy directly holds 1,241 shares of CHEMED CORP Capital Stock. This transaction reflects an equity compensation grant rather than an open-market purchase, increasing her direct ownership stake in the company.

Insights

Equity Compensation Analyst

Director received routine equity award, not an open-market purchase.

Director Eileen P. McCarthy was granted 386 shares of CHEMED CORP Capital Stock on May 18, 2026 at a reference value of $440.77 per share. The footnote labels this as an award of stock, indicating compensation rather than a discretionary market trade.

After the award, she directly holds 1,241 shares, so the grant represents a meaningful but not dominant portion of her visible holdings. With no derivative positions reported and no sales involved, this filing mainly documents standard director equity compensation, typically viewed as neutral from a signaling perspective.

Insider Trade Summary

Grant/Award: 386 shares

Grant/Award 1 txn

Insider McCarthy Eileen P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Capital Stock	386	$440.77	$170K

Holdings After Transaction: Capital Stock — 1,241 shares (Direct)

Footnotes (1)

1. F1. Award of stock

Key Figures

Shares awarded: 386 shares Award value per share: $440.77 per share Shares owned after award: 1,241 shares

3 metrics

Shares awarded 386 shares Grant of Capital Stock on May 18, 2026

Award value per share $440.77 per share Reference price for stock award on May 18, 2026

Shares owned after award 1,241 shares Total direct holdings following the reported transaction

Key Terms

Grant, award, or other acquisition, Capital Stock, Award of stock

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Capital Stock financial

"security_title: Capital Stock"

Capital stock is the total set of shares that represent ownership in a company, including different classes such as common and preferred stock. Think of it as the number and types of slices in a company’s ownership pie: it matters to investors because it determines voting power, entitlement to dividends, and how a company’s value is divided per share, so changes in capital stock can dilute holdings or alter per‑share metrics.

Award of stock financial

"footnote: Award of stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did CHEMED CORP (CHE) director Eileen P. McCarthy report?

Director Eileen P. McCarthy reported receiving an award of 386 CHEMED CORP Capital Stock shares. The Form 4 describes the transaction as a grant or award acquisition, documenting equity compensation rather than a market trade in the company’s stock.

Was the CHEMED CORP (CHE) transaction an open-market stock purchase?

No, the transaction was not an open-market purchase. It is coded as a grant or award acquisition, with a footnote calling it an award of stock, meaning the shares were granted as compensation instead of being bought on the open market.

How many CHEMED CORP (CHE) shares did Eileen P. McCarthy receive and at what value?

Eileen P. McCarthy received 386 shares of CHEMED CORP Capital Stock. The filing reports a transaction price of $440.77 per share, which is used as the reference value for this equity award of stock granted to the director.

What are Eileen P. McCarthy’s CHEMED CORP (CHE) holdings after this award?

After the award, Eileen P. McCarthy directly holds 1,241 shares of CHEMED CORP Capital Stock. This total includes the 386 shares granted in the reported transaction and reflects her direct ownership position following the equity compensation grant.

Does the CHEMED CORP (CHE) Form 4 show any stock sales or disposals?

The Form 4 does not report any sales or disposals. It shows a single acquisition transaction coded as a grant, award, or other acquisition, increasing the director’s direct holdings without any corresponding sale of CHEMED CORP shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 09:50 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCarthy Eileen P

(Last) (First) (Middle)

3515 78TH STREET

#2

(Street)

JACKSON HEIGHTS NEW YORK 11372

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Capital Stock	05/18/2026		A		386	A(1)	$440.77	1,241	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Award of stock

	Eileen P. McCarthy	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)